c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis.

"CONFLICTS OF INTEREST Derek A. Mann owns stock in, is employed by, received grants from, and owns intellectual property rights in FibroFind Ltd. Jack Leslie owns stock in Fibrofind Ltd. Fiona Oakley owns stock in, received grants from, and is employed by FibroFind Ltd. She owns stock in FibroFind IP Ltd and FF Estates Ltd."

"FUNDING INFORMATION This work was funded by a UK Medical Research Council PhD studentship to J.L.; program grants MR/K0019494/1 to D.A.M, and F.O.; and grant MR/R023026/1 to D.A.M, and F.O. A CRUK program grant, reference C18342/A23390, supports J.L. and D.A.M. H.L.R, D.A.M., and F.O. received Cancer Research UK funding through the HUNTER HCC expediter network award (C9380/A18084). The cross‐council Lifelong Health and Wellbeing initiative, funded by the Medical research Council (award reference i L016354), funds D.A.M and F.O. J.E.H. and N.D.P. were supported by Cancer Research UK grant C1443/A22095. M.Y.W.Z. was supported by a personal award from the Newton‐Mosharafa Fund and is currently funded by Newton Prize 2020. A.C. is funded by the W.E. Harker Foundation. D.G. is funded by the Newcastle CRUK Clinical Academic Training Programme. Funding information Cancer Research UK, Grant/Award Number: C1443/A22095, C18342/A23390, C9380/A18084 and Clinical Academic Training Programme to DG; Medical Research Council, Grant/Award Number: MR/K0019494/1, MR/R023026/1 and i L016354; Newton Fund, Grant/ Award Number: Newton prize 2020; Newton-Mosharafa Fund; W. E. Harker Foundation, Grant/Award Number: PhD studentship"